Market Overview

Medical bionics (artificial organs) refer to implantable medical electronics and equipment used in hospitals, clinics, and medical checkup centers.

The artificial organ market continues to see new device releases and advances in minimally invasive surgical techniques, with the exception of extracorporeal circulation devices. These techniques include surgical procedures using catheters or endoscopes. They are characterized by less bleeding and quicker recovery, thereby reducing the physical burden on patients. As percutaneous surgical devices, such as catheters and other medical equipment that deliver drugs or supplies by piercing the skin, become more widely adopted, more cases and products are impacting open-surgery devices.
Meanwhile, an increase in patients opting for medications to treat osteoporosis or rheumatoid arthritis has led to fluctuations in the number of surgeries—albeit to a limited extent—and is acting as a negative factor.

Although the number of cases involving medical bionics has recovered overall in FY2024, supply shortages caused by delays in production and transportation of overseas products since the previous year continue to affect the market. Medical equipment and device distributors have raised product prices due to rising production costs.
In this context, the estimated size of the medical bionics (artificial organs) market, consisting of 68 products from 34 categories, reached 692.683 billion yen in FY2024, which was a 2.5% increase from the previous fiscal year.

Noteworthy Topics

Trends of Six Neurosurgery Products

Of the six neurosurgery product markets, the cerebral aneurysm clip market experienced negative growth partly due to an increase in endovascular cerebral treatments. Shunt valves saw a slight increase. The number of open neurosurgery surgery cases is decreasing due to the increased use of embolic coils and other devices for cerebrovascular treatments. Despite the continued sluggishness of the artificial bone market, the market size for six neurosurgery products was estimated at 10.48 billion yen in FY2024, marking a 0.7% increase from the previous fiscal year. 

Future Outlook

The trends in medical bionics by specialty area are as follows:

In the field of cardiothoracic surgery and cardiovascular systems, the markets for transcatheter aortic valve implantation (TAVI) and transcatheter aortic valve replacement (TAVR) continue to grow partly due to new market entrants and increased adoption. In contrast, the artificial lung market is experiencing negative growth, and the artificial blood vessel market continues to decline.

In the field of orthopedics, the aging population is driving growth of both markets of artificial joints and spinal fixation systems.

The market for artificial kidneys and related products is projected to shrink slightly. This is due to a decrease in the annual number of hemodialysis patients, a reduction in the number of dialysis clinics, and a slower use of dialyzers, though both hemodiafiltration and hemodialysis are expected to increase, especially hemodiafiltration.

Research Outline